In their report WT1 expression was assessed with IHC staining using a monoclonal anti-WT1 antibody (clone 6f-H2) and samples were scored as positive (WT1 overexpression) when more than 10% of tumor cells were stained in either their cytoplasm or nucleus. This evidence concerns the gene WT1 and neoplasm.